1. Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis
   Yahui Grace Chiu et al, 2017, Expert Opinion on Biological Therapy CrossRef
2. Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: A case report and literature review
   Hitoshi Yoshimura et al, 2017, Oncology Letters CrossRef
3. Quantitative Analysis of Multimodal Skeletal SPECT/CT Reconstructions in Diagnosing Medication-related Osteonecrosis of the Jaw
   Michael Thomas Beck et al, 2021, Nuklearmedizin - NuclearMedicine CrossRef
4. Calreticulin inhibits inflammation‐induced osteoclastogenesis and bone resorption
   Charla R. Fischer et al, 2017, Journal of Orthopaedic Research CrossRef
5. Ineffectiveness of Antiresorptive Agent Drug Holidays in Osteoporosis Patients for Treatment of Medication-Related Osteonecrosis of the Jaw: Consideration from Immunohistological Observation of Osteoclast Suppression and Treatment Outcomes
   Keisuke Omori et al, 2022, International Journal of Environmental Research and Public Health CrossRef
6. Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ)
   Sebastian Hoefert et al, 2017, Journal of Cranio-Maxillofacial Surgery CrossRef
7. Artemether Inhibits RANKL-Induced Osteoclast Differentiation and Prevents Bone Loss in Ovariectomized Mice
   Ming-Xuan Feng et al, 2023, Revista Brasileira de Farmacognosia CrossRef
8. The relationship between genetic polymorphisms in apolipoprotein E (ApoE) gene and osteonecrosis of the femoral head induced by steroid in Chinese Han population
   Lin Yuan et al, 2018, Genes & Genomics CrossRef
9. Osteonecrosis of the Jaws. Prevalence, Risk Factors and Role of Microbiota and Inflammation in a Population of Spain
   Mario Pérez-Sayáns et al, 2017, Osteonecrosis CrossRef
10. Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw
    null null et al, 2017, Journal of Bone and Mineral Metabolism CrossRef
11. Denosumab
    , 2016, Reactions Weekly CrossRef
12. Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study
    Yuki Sakamoto et al, 2023, Scientific Reports CrossRef
13. Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis
    Kazumitsu Aoki et al, 2021, Journal of Bone and Mineral Metabolism CrossRef
14. Oral manifestation of systemic diseases—a perspective from an oral pathology diagnostic service
    G Bradley et al, 2018, Oral Diseases CrossRef
15. Differences Between Medication-Related Osteonecrosis of the Jaw Caused by Bisphosphonates and Denosumab: Histological, Molecular Biological, and Clinical Studies
    Taro Miyoshi et al, 2024, Cureus CrossRef